Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities

References

• Lansbury LE, Brown CS, Nguyen‐Van‐Tam JS. Influenza in long‐term care facilities. Influenza Other Respir Viruses. 2017;11(5):356–13. doi:10.1111/irv.12464.
   PubMed Web of Science ®Google Scholar
• Alti E, Ecarnot F, Maggi S, Michel J-P, Scotti S, Maio T. Immunizations in older adults. The Role of Family Physicians in Older People Care. 2022;89–105.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Influenza (flu): people at higher risk of flu complications; 2018 [accessed 2022 Sep 6]. https://www.cdc.gov/flu/highrisk/index.htm.
   Google Scholar
• Utsumi M, Makimoto K, Quroshi N, Ashida N. Types of infectious outbreaks and their impact in elderly care facilities: a review of the literature. Age Ageing. 2010;39(3):299–305. doi:10.1093/ageing/afq029.
   PubMed Web of Science ®Google Scholar
• Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019;23(1):1–7. doi:10.1186/s13054-019-2539-x.
   PubMedGoogle Scholar
• Tennant E, Fletcher S, Kakar S, Najjar Z, Lord H, Clark P, Gupta L. Factors associated with adverse outcomes during influenza outbreaks in aged care facilities. Aust NZJ Public Health. 2020;44(1):65–72. doi:10.1111/1753-6405.12933.
   PubMed Web of Science ®Google Scholar
• Rainwater‐Lovett K, Chun K, Lessler J. Influenza outbreak control practices and the effectiveness of interventions in long‐term care facilities: a systematic review. Influenza Other Respi Viruses. 2014;8(1):74–82. doi:10.1111/irv.12203.
   PubMed Web of Science ®Google Scholar
• Dean AS, Moffatt CRM, Rosewell A, Dwyer DE, Lindley RI, Booy R, MacIntyre CR. Incompletely matched influenza vaccine still provides protection in frail elderly. Vaccine. 2010;28(3):864–7. doi:10.1016/j.vaccine.2009.03.024.
   PubMed Web of Science ®Google Scholar
• Group SW. Background paper on influenza vaccines and immunization. Geneva: World Health Organization; 2012. p. 463.
   Google Scholar
• Lee MH, Lee GA, Lee SH, Park Y-H, Lansbury LE. A systematic review on the causes of the transmission and control measures of outbreaks in long-term care facilities: back to basics of infection control. PloS One. 2020;15(3):e0229911. doi:10.1371/journal.pone.0229911.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Al‐Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010;2010(2). doi:10.1002/14651858.CD004876.pub3.
   PubMedGoogle Scholar
• Rondy M, El Omeiri N, Thompson MG, Levêque A, Moren A, Sullivan SG. Effectiveness of influenza vaccines in preventing severe influenza illness among adults: a systematic review and meta-analysis of test-negative design case-control studies. J Infect. 2017;75(5):381–94. doi:10.1016/j.jinf.2017.09.010.
   PubMed Web of Science ®Google Scholar
• Chan T-C, Hung I-N, Luk J-H, Chu L-W, Chan F-W. Effectiveness of influenza vaccination in institutionalized older adults: a systematic review. J Am Med Dir Assoc. 2014;15(3):e226.1–.e6. doi:10.1016/j.jamda.2013.10.008.
   Web of Science ®Google Scholar
• Weissman YL, Cooper L, Sternbach N, Ashkenazi-Hoffnung L, Yahav D. Clinical efficacy and safety of high dose trivalent influenza vaccine in adults and immunosuppressed populations–A systematic review and meta-analysis. J Infect. 2021;83(4):444–51. doi:10.1016/j.jinf.2021.08.028.
   PubMed Web of Science ®Google Scholar
• Coleman BL, Sanderson R, Haag MD, McGovern I. Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis. Influenza Other Respi Viruses. 2021;15(6):813–23. doi:10.1111/irv.12871.
   PubMed Web of Science ®Google Scholar
• Lee JK, Lam GK, Shin T, Samson SI, Greenberg DP, Chit A. Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: an updated systematic review and meta-analysis. Vaccine. 2021;39:A24–A35. doi:10.1016/j.vaccine.2020.09.004.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366(9492):1165–74. doi:10.1016/S0140-6736(05)67339-4.
   PubMed Web of Science ®Google Scholar
• Nace DA, Lin CJ, Ross TM, Saracco S, Churilla RM, Zimmerman RK. Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities. J Infect Dis. 2014;211(12):1915–24. doi:10.1093/infdis/jiu622.
   PubMed Web of Science ®Google Scholar
• Pawelec G, McElhaney J. Recent advances in influenza vaccines. F1000Res. 2020;9:305. doi:10.12688/f1000research.22611.1.
   Google Scholar
• Kim YH, Hong KJ, Kim H, Nam JH. Influenza vaccines: past, present, and future. Rev Med Virol. 2022;32(1):e2243. doi:10.1002/rmv.2243.
   PubMed Web of Science ®Google Scholar
• Lang P-O, Mendes A, Socquet J, Assir N, Govind S, Aspinall R. Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging. 2012;55–64. doi:10.2147/CIA.S25215.
   PubMed Web of Science ®Google Scholar
• McElhaney JE, Andrew MK, Haynes L, Kuchel GA, McNeil SA, Pawelec G. Influenza vaccination: accelerating the process for new vaccine development in older adults. Vaccines Older Adults. 2020;43:98–112.
   Google Scholar
• Arya S, Kaji AH, Boermeester MA. PRISMA reporting guidelines for meta-analyses and systematic reviews. JAMA Surg. 2021;156(8):789–90. doi:10.1001/jamasurg.2021.0546.
   PubMed Web of Science ®Google Scholar
• Moola S. Chapter 7: systematic reviews of etiology and risk. Aromataris E, Munn Z. Joanna Briggs Institute Reviewer’s Manual The Joanna Briggs Institute; 2017.
   Google Scholar
• Kunasekaran M, Moa A, Hooshmand E, Trent M, Poulos CJ, Chughtai AA, Heslop DJ, Raina MacIntyre C. Effectiveness estimates for enhanced trivalent influenza vaccines in an aged care summer outbreak. Vaccine. 2022;40(50):7170–5. doi:10.1016/j.vaccine.2022.06.018.
   PubMed Web of Science ®Google Scholar
• Ng Y, Nandar K, Chua LAV, Mak TM, Foo K, Muhammad IR, Low CKK, Ma S, Ooi SPL, Lin RTP, et al. Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore’s long term care facilities, 2017. Vaccine. 2019;37(29):3925–31. doi:10.1016/j.vaccine.2019.03.054.
   PubMed Web of Science ®Google Scholar
• Van Buynder P, Konrad S, Van Buynder J, Brodkin E, Krajden M, Ramler G, Bigham M. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine. 2013;31(51):6122–8. doi:10.1016/j.vaccine.2013.07.059.
   PubMed Web of Science ®Google Scholar
• Guy R, Lambert S, Kelly H. Estimating influenza vaccine effectiveness in an outbreak when anti‐viral medications were used as a control measure. Aust NZJ Public Health. 2005;29(6):540–3. doi:10.1111/j.1467-842X.2005.tb00247.x.
   PubMed Web of Science ®Google Scholar
• Deguchi Y, Takasugi Y, Tatara K. Efficacy of influenza vaccine in the elderly in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza a (H3N2) epidemic. J Med Microbiol. 2000;49(6):553–6. doi:10.1099/0022-1317-49-6-553.
   PubMed Web of Science ®Google Scholar
• Taylor JL, Dwyer DM, Coffman T, Groves C, Patel J, Israel E. Nursing home outbreak of influenza a (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infect Cont Hosp Ep. 1992;13(2):93–7. doi:10.2307/30147067.
   PubMed Web of Science ®Google Scholar
• Coles FB, Balzano GJ, Morse DL. An outbreak of influenza a (H3N2) in a well immunized nursing home population. J Am Geriatr Soc. 1992;40(6):589–92. doi:10.1111/j.1532-5415.1992.tb02108.x.
   PubMed Web of Science ®Google Scholar
• Cartter ML, Renzullo PO, Helgerson SD, Martin SM, Jekel JF. Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly? Infect Cont Hosp Ep. 1990;11(9):473–8. doi:10.2307/30146979.
   PubMed Web of Science ®Google Scholar
• Meiklejohn G, Hoffman R, Graves P. Effectiveness of influenza vaccine when given during an outbreak of influenza A/H3N2 in a nursing home. J Am Geriatr Soc. 1989;37(5):407–10. doi:10.1111/j.1532-5415.1989.tb02635.x.
   PubMed Web of Science ®Google Scholar
• Horman JT, Stetler HC, Israel E, Sorley D, Schipper MT, Joseph JM. An outbreak of influenza a in a nursing home. Am J Public Health. 1986;76(5):501–4. doi:10.2105/AJPH.76.5.501.
   PubMed Web of Science ®Google Scholar
• Goodman RA, Orenstein WA, Munro TF, Smith SC, Sikes RK. Impact of influenza a in a nursing home. JAMA. 1982;247(10):1451–3. doi:10.1001/jama.1982.03320350055031.
   PubMed Web of Science ®Google Scholar
• Gravenstein S, McConeghy KW, Saade E, Davidson HE, Canaday DH, Han L, Rudolph J, Joyce N, Dahabreh IJ, Mor V, et al. Adjuvanted influenza vaccine and influenza outbreaks in US nursing homes: results from a pragmatic cluster-randomized clinical trial. Clin Infect Dis. 2021;73(11):e4229–e36. doi:10.1093/cid/ciaa1916.
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O’Brien D, Dolin R, Betts RF. Protective efficacy of combined live intranasal and inactivated influenza a virus vaccines in the elderly. Ann Intern Med. 1992;117(8):625–33. doi:10.7326/0003-4819-117-8-625.
   PubMed Web of Science ®Google Scholar
• Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7(10):658–66. doi:10.1016/S1473-3099(07)70236-0.
   PubMed Web of Science ®Google Scholar
• Jones RP, Ponomarenko A. Roles for pathogen interference in influenza vaccination, with implications to vaccine effectiveness (VE) and attribution of influenza deaths. Infect Dis Rep. 2022;14(5):710–58. doi:10.3390/idr14050076.
   PubMed Web of Science ®Google Scholar
• Schmidt SSS, Iuliano AD, Vestergaard LS, Mazagatos-Ateca C, Larrauri A, Brauner JM, Olsen SJ, Nielsen J, Salomon JA, Krause TG, et al. All-cause versus cause-specific excess deaths for estimating influenza-associated mortality in Denmark, Spain, and the United States. Influenza Other Respir Viruses. 2022;16(4):707–16. doi:10.1111/irv.12966.
   PubMed Web of Science ®Google Scholar
• Hong K, Sohn S, Chun BC. Estimating influenza-associated mortality in Korea: the 2009-2016 seasons. J Prev Med Public Health. 2019;52(5):308–15. doi:10.3961/jpmph.19.156.
   PubMedGoogle Scholar
• Vestergaard LS, Nielsen J, Krause TG, Espenhain L, Tersago K, Bustos Sierra N, Denissov G, Innos K, Virtanen MJ, Fouillet A, et al. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017. Eurosurveillance. 2017;22(14):30506. doi:10.2807/1560-7917.ES.2017.22.14.30506.
   Web of Science ®Google Scholar
• Darvishian M, Bijlsma MJ, Hak E, van den Heuvel ER. Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. Lancet Infect Dis. 2014;14(12):1228–39. doi:10.1016/S1473-3099(14)70960-0.
   PubMed Web of Science ®Google Scholar
• Darvishian M, van den Heuvel ER, Bissielo A, Castilla J, Cohen C, Englund H, Gefenaite G, Huang W-T, la Bastide-van Gemert S, Martinez-Baz I, et al. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies. Lancet Respir Med. 2017;5(3):200–11. doi:10.1016/S2213-2600(17)30043-7.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Ikeda S, Hagiwara Y, Tsuzuki D, Klai M, Sakai Y, Crawford B, Nealon J. Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: a systematic literature review and vaccine effectiveness meta-analysis. Influenza Other Respi Viruses. 2021;15(2):293–314. doi:10.1111/irv.12814.
   PubMed Web of Science ®Google Scholar
• Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995;123(7):518–27. doi:10.7326/0003-4819-123-7-199510010-00008.
   PubMed Web of Science ®Google Scholar
• Chung H, Buchan SA, Campigotto A, Campitelli MA, Crowcroft NS, Dubey V, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, et al. Influenza vaccine effectiveness against all-cause mortality Following laboratory-confirmed influenza in older adults, 2010–2011 to 2015–2016 seasons in Ontario, Canada. Clin Infect Dis. 2021;73(5):e1191–e9. doi:10.1093/cid/ciaa1862.
   PubMed Web of Science ®Google Scholar
• Yedlapati SH, Khan SU, Talluri S, Lone AN, Khan MZ, Khan MS, Navar AM, Gulati M, Johnson H, Baum S, et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc. 2021;10(6):e019636. doi:10.1161/JAHA.120.019636.
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Dunning AJ, Jordanov E, Landolfi V, Denis M, Talbot HK. High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009–2010 season. Vaccine. 2013;31(6):861–6. doi:10.1016/j.vaccine.2012.12.013.
   PubMed Web of Science ®Google Scholar
• DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, Pollak R, Christoff J, Earl J, Landolfi V, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371(7):635–45. doi:10.1056/NEJMoa1315727.
   PubMed Web of Science ®Google Scholar
• Gravenstein S, Davidson HE, Taljaard M, Ogarek J, Gozalo P, Han L, Mor V. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. Lancet Respir Med. 2017;5(9):738–46. doi:10.1016/S2213-2600(17)30235-7.
   PubMed Web of Science ®Google Scholar
• Izurieta HS, Thadani N, Shay DK, Lu Y, Maurer A, Foppa IM, Franks R, Pratt D, Forshee RA, MaCurdy T, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using medicare data: a retrospective cohort analysis. Lancet Infect Dis. 2015;15(3):293–300. doi:10.1016/S1473-3099(14)71087-4.
   PubMed Web of Science ®Google Scholar
• Robison SG, Thomas AR. Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design. Vaccine. 2018;36(45):6683–7. doi:10.1016/j.vaccine.2018.09.050.
   PubMed Web of Science ®Google Scholar
• Pelton SI, Divino V, Shah D, Mould-Quevedo J, DeKoven M, Krishnarajah G, Postma MJ. Evaluating the relative vaccine effectiveness of adjuvanted trivalent influenza vaccine compared to high-dose trivalent and other egg-based influenza vaccines among older adults in the US during the 2017–2018 influenza season. Vaccines. 2020;8(3):446. doi:10.3390/vaccines8030446.
   Web of Science ®Google Scholar
• Gärtner BC, Weinke T, Wahle K, Kwetkat A, Beier D, Schmidt KJ, Schwarz TF. Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective – a systematic review of recently published literature on real-world data. Vaccine. 2022;40(22):2999–3008. doi:10.1016/j.vaccine.2022.04.019.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Influenza (Flu). Live attenuated influenza vaccine [LAIV] (the nasal spray flu vaccine). [accessed 2023 Sep 5]. https://www.cdc.gov/flu/prevent/nasalspray.htm.
   Google Scholar
• Jones RP, Ponomarenko A. System complexity in influenza infection and vaccination: effects upon excess Winter mortality. Infect Dis Rep. 2022;14(3):287–309. doi:10.3390/idr14030035.
   PubMed Web of Science ®Google Scholar
• Lee JKH, Lam GKL, Shin T, Samson SI, Greenberg DP, Chit A. Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: an updated systematic review and meta-analysis. Vaccine. 2021;39(Suppl 1):A24–a35. doi:10.1016/j.vaccine.2020.09.004.
   PubMed Web of Science ®Google Scholar
• Moa AM, Adam DC, MacIntyre CR. Inter-seasonality of influenza in Australia. Influenza Other Respi Viruses. 2019;13(5):459–64. doi:10.1111/irv.12642.
   PubMed Web of Science ®Google Scholar
• Sullivan SG, Chilver MB, Carville KS, Deng Y-M, Grant KA, Higgins G, Komadina N, Leung VK, Minney-Smith CA, Teng D, et al. Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. Eurosurveillance. 2017;22(43):17–00707. doi:10.2807/1560-7917.ES.2017.22.43.17-00707.
   Web of Science ®Google Scholar
• Andrew MK, Bowles SK, Pawelec G, Haynes L, Kuchel GA, McNeil SA, McElhaney JE. Influenza vaccination in older adults: recent innovations and practical applications. Drugs Aging. 2019;36:29–37. doi:10.1007/s40266-018-0597-4.
   PubMed Web of Science ®Google Scholar
• Langer J, Welch VL, Moran MM, Cane A, Lopez SM, Srivastava A, Enstone AL, Sears A, Markus KJ, Heuser M, et al. High clinical burden of influenza disease in adults aged≥ 65 years: can we do better? A systematic literature review. Adv Ther. 2023;40(4):1601–27. doi:10.1007/s12325-023-02432-1.
   PubMed Web of Science ®Google Scholar
• Ramsay LC, Buchan SA, Stirling RG, Cowling BJ, Feng S, Kwong JC, Warshawsky BF. The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis. BMC Med. 2019;17(1):9. doi:10.1186/s12916-018-1239-8.
   PubMed Web of Science ®Google Scholar
• Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horváth JK, Domegan L, Pitigoi D, Machado A, Paradowska-Stankiewicz IA, et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE multicentre case–control study, Europe 2014/15. Eurosurveillance. 2016;21(7):30139. doi:10.2807/1560-7917.ES.2016.21.7.30139.
   Web of Science ®Google Scholar
• Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, McLean HQ. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016;16(8):942–51. doi:10.1016/S1473-3099(16)00129-8.
   PubMed Web of Science ®Google Scholar
• Baldo V, Bertoncello C, Cocchio S, Fonzo M, Pillon P, Buja A, Baldovin T. The new pandemic influenza A/(H1N1)pdm09 virus: is it really “new”? J Prev Med Hyg. 2016;57(1):E19–22.
   PubMedGoogle Scholar
• Simonsen L, Spreeuwenberg P, Lustig R, Taylor RJ, Fleming DM, Kroneman M, Van Kerkhove MD, Mounts AW, Paget WJ, GLaMOR Collaborating Teams. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013;10(11):e1001558. doi:10.1371/journal.pmed.1001558.
   PubMed Web of Science ®Google Scholar
• Frasca D, Blomberg BB. Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination. Immun Ageing. 2020;17(1):37. doi:10.1186/s12979-020-00210-z.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Aleem MA, Roguski K, Abedin J, Islam A, Alam KF, Gurley ES, Rahman M, Azziz‐Baumgartner E, Homaira N, et al. Estimates of seasonal influenza‐associated mortality in Bangladesh, 2010‐2012. Influenza Other Respi Viruses. 2018;12(1):65–71. doi:10.1111/irv.12490.
   PubMed Web of Science ®Google Scholar
• Ross ZP, Komadina N, Deng Y-M, Spirason N, Kelly HA, Sullivan SG, Barr IG, Holmes EC. Inter-seasonal influenza is characterized by extended virus transmission and persistence. PLoS Pathog. 2015;11(6):e1004991. doi:10.1371/journal.ppat.1004991.
   PubMed Web of Science ®Google Scholar
• Aungkulanon S, Cheng PY, Kusreesakul K, Bundhamcharoen K, Chittaganpitch M, Margaret M, Olsen S. Influenza‐associated mortality in T hailand, 2 006–2011. Influenza Other Respi Viruses. 2015;9(6):298–304. doi:10.1111/irv.12344.
   PubMed Web of Science ®Google Scholar
• Wu P, Goldstein E, Ho LM, Yang L, Nishiura H, Wu JT, Ip DKM, Chuang S-K, Tsang T, Cowling BJ, et al. Excess mortality associated with influenza a and B virus in Hong Kong, 1998–2009. J Infect Dis. 2012;206(12):1862–71. doi:10.1093/infdis/jis628.
   PubMed Web of Science ®Google Scholar
• Ghedin E, Wentworth DE, Halpin RA, Lin X, Bera J, DePasse J, Fitch A, Griesemer S, Hine E, Katzel DA, et al. Unseasonal transmission of H3N2 influenza a virus during the swine-origin H1N1 pandemic. J Virol. 2010;84(11):5715–8. doi:10.1128/JVI.00018-10.
   PubMed Web of Science ®Google Scholar
• Costantino V, Trent M, MacIntyre CR. Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage. Vaccine. 2019;37(44):6768–75. doi:10.1016/j.vaccine.2019.08.069.
   PubMed Web of Science ®Google Scholar
• Zhang A, Stacey HD, Mullarkey CE, Miller MS. Original antigenic sin: how first exposure shapes lifelong anti–influenza virus immune responses. J Immunol. 2019;202(2):335–40. doi:10.4049/jimmunol.1801149.
   PubMed Web of Science ®Google Scholar
• Jones-Gray E, Robinson EJ, Kucharski AJ, Fox A, Sullivan SG. Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis. Lancet Respir Med. 2022;11:27–44. doi:10.1016/S2213-2600(22)00266-1.
   PubMed Web of Science ®Google Scholar
• Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines. 2017;16(7):723–36. doi:10.1080/14760584.2017.1334554.
   PubMed Web of Science ®Google Scholar
• Havasi A, Visan S, Cainap C, Cainap SS, Mihaila AA, Pop L-A. Influenza A, influenza B, and SARS-CoV-2 similarities and differences–a focus on diagnosis. Front Microbiol. 2022;13:2148. doi:10.3389/fmicb.2022.908525.
   Web of Science ®Google Scholar
• Soiza RL, Scicluna C, Bilal S. Virus infections in older people. Subcell Biochem. 2023;103:149–183. doi:10.1007/978-3-031-26576-1_8.
   Google Scholar
• Bartlow AW, Stromberg ZR, Gleasner CD, Hu B, Davenport KW, Jakhar S, Li P-E, Vosburg M, Garimella M, Chain PSG, et al. Comparing variability in diagnosis of upper respiratory tract infections in patients using syndromic, next generation sequencing, and PCR-based methods. PLOS Glob Public Health. 2022;2(7):e0000811. doi:10.1371/journal.pgph.0000811.
   PubMedGoogle Scholar
• Trombetta CM, Kistner O, Montomoli E, Viviani S, Marchi S. Influenza Viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines. Vaccines. 2022;10(5):714. doi:10.3390/vaccines10050714.
   Web of Science ®Google Scholar
• Saade EA, Abul Y, McConeghy K, Edward Davidson H, Han L, Joyce N, Canaday DH, Hsueh L, Bosco E, Gravenstein S, et al. High-dose influenza vaccines for the prevention of hospitalization due to cardiovascular events in older adults in the nursing home: post-hoc analysis of a cluster-randomized trial. Vaccine. 2022;40(47):6700–5. doi:10.1016/j.vaccine.2022.09.085.
   PubMedGoogle Scholar
• Gravenstein S, Davidson HE, Han LF, Ogarek JA, Dahal R, Gozalo PL, Taljaard M, Mor V. Feasibility of a cluster-randomized influenza vaccination trial in US nursing homes: lessons learned. Hum Vaccin Immunother. 2018;14(3):736–43. doi:10.1080/21645515.2017.1398872.
   PubMed Web of Science ®Google Scholar
• Soo RJJ, Chiew CJ, Ma S, Pung R, Lee V. Decreased influenza incidence under COVID-19 control measures, Singapore. Emerg Infect Dis. 2020;26(8):1933. doi:10.3201/eid2608.201229.
   PubMed Web of Science ®Google Scholar
• Suntronwong N, Thongpan I, Chuchaona W, Budi Lestari F, Vichaiwattana P, Yorsaeng R, Pasittungkul S, Kitphati R, Vongpunsawad S, Poovorawan Y, et al. Impact of COVID-19 public health interventions on influenza incidence in Thailand. Pathog Glob Health. 2020;114:1–3. doi:10.1080/20477724.2020.1777803.
   PubMed Web of Science ®Google Scholar
• Lei H, Xu M, Wang X, Xie Y, Du X, Chen T, Yang L, Wang D, Shu Y. Nonpharmaceutical interventions used to control COVID-19 reduced seasonal influenza transmission in China. J Infect Dis. 2020;222(11):1780–3. doi:10.1093/infdis/jiaa570.
   PubMed Web of Science ®Google Scholar
• Kuo S-C, Shih S-M, Chien L-H, Hsiung CA. Collateral benefit of COVID-19 control measures on influenza activity, Taiwan. Emerg Infect Dis. 2020;26(8):1928. doi:10.3201/eid2608.201192.
   PubMed Web of Science ®Google Scholar
• Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, Nesdale A, Dowell T, Turner N, Campbell-Stokes P, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12(1):1–7. doi:10.1038/s41467-021-21157-9.
   PubMed Web of Science ®Google Scholar
• Akhtar Z, Chowdhury F, Rahman M, Ghosh PK, Ahmmed MK, Islam MA, Mott JA, Davis W. Seasonal influenza during the COVID-19 pandemic in Bangladesh. PloS One. 2021;16(8):e0255646. doi:10.1371/journal.pone.0255646.
   PubMed Web of Science ®Google Scholar